ArticleInternational journal of hematology2021
A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myeloma.
Shinsuke Iida et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it